Key result
CPA6 inhibition reduces enterovirus replication and limits intestinal viral burden and tissue injury in mice.
Why the study?
Bovine enterovirus is an understudied pathogen causing bovine enteric and respiratory disease, and host factors supporting its infection remain poorly defined.
CPA6 is a previously unrecognized host factor for BEV-F infection, suggesting carboxypeptidase-associated pathways as potential antiviral targets.
Answers are grounded in this paper and cite their sources.
CPA6 inhibition attenuates BEV-F in mice; leaves open whether carboxypeptidase pathways are viable antiviral targets beyond animal models.
Bovine enterovirus (BEV), a member of the family Picornaviridae, is an understudied pathogen associated with bovine enteric and respiratory disease, and host factors supporting its infection remain poorly defined. Here, a genome-wide CRISPR/Cas9 loss-of-function screen in Madin–Darby bovine kidney cells identified carboxypeptidase A6 (CPA6) as a candidate host factor for BEV-F infection. CPA6 deficiency impaired productive BEV-F infection, as shown by reduced viral titers, extracellular viral RNA, and viral protein expression, whereas CPA6 complementation restored these phenotypes. Stage-specific analyses indicated that CPA6 did not significantly affect viral attachment or internalization but contributed to late-stage infection associated with extracellular viral accumulation. BEV-F infection induced CPA6 expression and apoptosis, while CPA6 deficiency significantly attenuated virus-induced apoptosis. Further analyses showed that CPA6 loss enhanced PI3K/AKT signaling, increased FOXO1 phosphorylation, and reduced nuclear FOXO1 localization during infection. Pharmacological inhibition of PI3K in CPA6-knockout cells partially restored FOXO1 nuclear accumulation, apoptosis, and viral production, indicating a functional association between CPA6 and the PI3K/AKT/FOXO1 axis. Rescue experiments using wild-type CPA6 and a catalytic mutant further showed that CPA6 enzymatic activity contributed substantially to viral production, FOXO1 regulation, and apoptosis. Finally, inhibition of carboxypeptidase-associated activity with 2-benzylsuccinic acid reduced BEV-F infection in vitro and lowered intestinal viral burden and tissue injury in mice. Collectively, these findings identify CPA6 as a previously unrecognized host factor for BEV-F infection, support a model in which CPA6 is functionally associated with PI3K/AKT/FOXO1 signaling related to apoptosis, and suggest that carboxypeptidase-associated pathways may represent potential avenues for antiviral intervention.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2026) studied Bovine enterovirus F (BEV-F) infection (n=15). CPA6 knockout and 2-benzylsuccinic acid vs. Wild-type and DMSO control was evaluated on Viral production and intestinal tissue injury. CPA6 deficiency or pharmacological inhibition with 2-benzylsuccinic acid reduced BEV-F viral production in vitro and lowered intestinal viral burden and tissue injury in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: